IL6 and type 2 diabetes mellitus: Consequently, this study was conducted to explore the association between SUA levels, serum oxido-inflammatory biomarkers, such as tumor necrosis factor-alpha (TNF-α), interleukin 6 (IL-6), C-reactive protein (CRP), total antioxidant capacity (TAC), and malondialdehyde (MDA), and the risk of CAD among patients with T2DM as the primary outcome.